Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · IEX Real-Time Price · USD
3.060
0.00 (0.00%)
At close: May 31, 2024, 4:00 PM
2.950
-0.110 (-3.59%)
After-hours: May 31, 2024, 5:47 PM EDT
Ovid Therapeutics Market Cap
Ovid Therapeutics has a market cap or net worth of $217.09 million as of May 31, 2024. Its market cap has decreased by -11.54% in one year.
Market Cap
217.09M
Enterprise Value
170.60M
1-Year Change
-11.54%
Ranking
Category
Stock Price
$3.06
Market Cap Chart
Since May 5, 2017, Ovid Therapeutics's market cap has decreased from $301.40M to $217.09M, a decrease of -27.97%. That is a compound annual growth rate of -4.53%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 31, 2024 | 217.10M | - |
May 30, 2024 | 217.10M | 2.02% |
May 29, 2024 | 212.80M | -1.66% |
May 28, 2024 | 216.40M | 1.69% |
May 24, 2024 | 212.80M | -0.33% |
May 23, 2024 | 213.50M | -6.85% |
May 22, 2024 | 229.20M | 3.90% |
May 21, 2024 | 220.60M | -0.99% |
May 20, 2024 | 222.80M | -0.31% |
May 17, 2024 | 223.50M | -3.79% |
May 16, 2024 | 232.30M | -1.36% |
May 15, 2024 | 235.50M | 2.75% |
May 14, 2024 | 229.20M | 7.35% |
May 13, 2024 | 213.50M | 0.66% |
May 10, 2024 | 212.10M | -1.67% |
May 9, 2024 | 215.70M | -1.28% |
May 8, 2024 | 218.50M | 3.02% |
May 7, 2024 | 212.10M | -0.66% |
May 6, 2024 | 213.50M | -1.34% |
May 3, 2024 | 216.40M | -0.32% |
May 2, 2024 | 217.10M | 0.32% |
May 1, 2024 | 216.40M | 0.32% |
Apr 30, 2024 | 215.70M | -8.68% |
Apr 29, 2024 | 236.20M | 7.76% |
Apr 26, 2024 | 219.20M | 3.69% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Renovaro Biosciences | 219.78M |
Elevation Oncology | 219.65M |
Invivyd | 219.54M |
2seventy bio | 217.44M |
908 Devices | 217.26M |
Quantum-Si incorporated | 215.56M |
Generation Bio Co. | 211.56M |
Prelude Therapeutics | 211.48M |